1. Review the history of discovery of PCSK9 and the first inhibitors.
2. Understand siRNA approaches to PCSK9 anatagonism.
3. Become aware of the pipeline of anti-PCSK9 therapies.
05/13/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Michael Shapiro, DO